{
  "ticker": "LLY",
  "target_date": "2025-02-06",
  "actual_date": "2025-02-06",
  "collected_at": "2025-12-08T11:22:19.951930",
  "price": {
    "open": 833.3,
    "high": 881.17,
    "low": 829.42,
    "close": 863.9260864257812,
    "volume": 7138500,
    "change_1d_pct": 3.35,
    "change_7d_pct": 8.12,
    "change_30d_pct": 13.36
  },
  "technicals": {
    "rsi_14": 76.81,
    "sma_20": 784.57,
    "sma_50": 782.39,
    "macd": 16.631,
    "macd_signal": 7.152,
    "macd_histogram": 9.479,
    "bb_upper": 858.83,
    "bb_lower": 710.32,
    "price_vs_sma20_pct": 10.11,
    "price_vs_sma50_pct": 10.42,
    "volume_ratio": 1.69
  },
  "fundamentals": {
    "market_cap": 891490336768,
    "pe_ratio": 48.72415,
    "forward_pe": 43.88614,
    "price_to_book": 37.442017,
    "price_to_sales": 15.003254,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.57,
    "pct_from_52w_low": 59.42
  },
  "macro": {
    "spy": {
      "price": 601.05,
      "change_1d_pct": 0.35,
      "change_7d_pct": 0.75
    },
    "vix": {
      "level": 15.5,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.44
    },
    "dollar_index": {
      "level": 107.69
    },
    "gold": {
      "price": 2856.0
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Eli Lilly Q4: Don't Miss Out On 2025 Gains, There's Limited Space Left",
      "source": "SeekingAlpha",
      "datetime": 1738879930,
      "summary": "Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and pricing challenges loom. See more here.",
      "url": "https://finnhub.io/api/news?id=3034fc1c618b515fa749d36cbda51fe57b5acd6b4b6b98831319c66a405452c8"
    },
    {
      "headline": "Health Care Climbs After Lilly Earnings - Health Care Roundup",
      "source": "MarketWatch",
      "datetime": 1738862460,
      "summary": "Health Care Climbs After Lilly Earnings - Health Care Roundup",
      "url": "https://finnhub.io/api/news?id=c5fe41566f9469ac1656783a3ad4e9285f9be807077deda0c5c1d091e7e7b209"
    },
    {
      "headline": "Amgen Stock Has Surged. Here\u2019s Where It\u2019s Headed Next.",
      "source": "MarketWatch",
      "datetime": 1738858620,
      "summary": "Amgen Stock Has Surged. Here\u2019s Where It\u2019s Headed Next.",
      "url": "https://finnhub.io/api/news?id=ad5b172ec4ba2f3a6e56b0ff80084faf18034c4cc6c82f439cdb65ce7fd76f04"
    },
    {
      "headline": "Eli Lilly Q4 Earnings: Now The Magical $1 Trillion Dollar Market Cap Is In Sight",
      "source": "SeekingAlpha",
      "datetime": 1738856271,
      "summary": "Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline. Click for my LLY stock update.",
      "url": "https://finnhub.io/api/news?id=dd17313f5bed105c7779521cff776d564d6fc8881080b01cb6fba4fc4acd9d37"
    },
    {
      "headline": "Eli Lilly and Company (LLY) Q4 2024 Earnings Call Transcript",
      "source": "SeekingAlpha",
      "datetime": 1738851786,
      "summary": "Eli Lilly and Company (NYSE:LLY) Q4 2024 Results Conference Call February 6, 2025 10:00 AM ETCompany ParticipantsMike Czapar - Senior Vice President of...",
      "url": "https://finnhub.io/api/news?id=2bbed3aba2f6028881ddbdb446d817f73f824c1f7863b5e62f3517c0bf854352"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "8-K",
      "date": "2025-02-06",
      "description": "lly-20250206.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000037/lly-20250206.htm"
    },
    {
      "form": "4",
      "date": "2025-02-04",
      "description": "xslF345X05/wk-form4_1738704486.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000034/xslF345X05/wk-form4_1738704486.xml"
    },
    {
      "form": "4",
      "date": "2025-02-04",
      "description": "xslF345X05/wk-form4_1738704436.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000032/xslF345X05/wk-form4_1738704436.xml"
    },
    {
      "form": "4",
      "date": "2025-02-04",
      "description": "xslF345X05/wk-form4_1738704376.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000030/xslF345X05/wk-form4_1738704376.xml"
    },
    {
      "form": "4",
      "date": "2025-02-04",
      "description": "xslF345X05/wk-form4_1738704326.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000028/xslF345X05/wk-form4_1738704326.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}